Affinivax' shot performed better than Prevnar 13 against serotype 3 – arguably the most problematic variant in terms of clinical severity – at all doses, and against serotypes 5 and 19F at the ...
The Prevnar 20 approval comes a few weeks ahead of an FDA decision on Merck's V114, which was granted a priority review by the regulator in January for the prevention of IPD in adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback